TABLE 3.
Absorbed dose, mGy/MBq | |||
---|---|---|---|
Site | 1,000 μg | 2,000 μg | 3,000 μg |
Adrenals | 0.031 ± 0.007 | 0.031 ± 0.007 | 0.032 ± 0.002 |
Brain | 0.0010 ± 0.0004 | 0.0011 ± 0.0002 | 0.0012 ± 0.0001 |
Breasts | 0.008 ± 0.002 | 0.007 ± 0.001 | 0.008 ± 0.001 |
Gallbladder wall | 0.017 ± 0.003 | 0.015 ± 0.004 | 0.014 ± 0.002 |
LLI wall | 0.005 ± 0.001 | 0.006 ± 0.003 | 0.006 ± 0.001 |
Small intestine | 0.0076 ± 0.0010 | 0.009 ± 0.004 | 0.009 ± 0.002 |
Stomach wall | 0.0060 ± 0.0008 | 0.006 ± 0.001 | 0.007 ± 0.002 |
ULI wall | 0.007 ± 0.001 | 0.008 ± 0.003 | 0.009 ± 0.002 |
Heart wall | 0.004 ± 0.001 | 0.004 ± 0.001 | 0.0042 ± 0.0007 |
Kidneys | 0.10 ± 0.02 | 0.10 ± 0.03 | 0.13 ± 0.05 |
Liver | 0.016 ± 0.003 | 0.011 ± 0.003* | 0.0100 ± 0.0008* |
Lungs | 0.005 ± 0.001 | 0.005 ± 0.001 | 0.006 ± 0.001 |
Muscle | 0.0024 ± 0.0005 | 0.003 ± 0.001 | 0.0028 ± 0.0007 |
Ovaries | 0.014 ± 0.005 | 0.014 ± 0.008 | 0.013 ± 0.003 |
Pancreas | 0.012 ± 0.001 | 0.013 ± 0.003 | 0.016 ± 0.004 |
Red marrow | 0.0033 ± 0.0007 | 0.004 ± 0.001 | 0.004 ± 0.001 |
Osteogenic cells | 0.006 ± 0.002 | 0.006 ± 0.002 | 0.007 ± 0.001 |
Skin | 0.0014 ± 0.0004 | 0.0015 ± 0.0003 | 0.0017 ± 0.0003 |
Spleen | 0.010 ± 0.001 | 0.010 ± 0.003 | 0.012 ± 0.004 |
Thymus | 0.006 ± 0.001 | 0.007 ± 0.003 | 0.0068 ± 0.0002 |
Thyroid | 0.017 ± 0.003 | 0.018 ± 0.005 | 0.022 ± 0.003 |
Urinary bladder wall | 0.013 ± 0.007 | 0.014 ± 0.009 | 0.019 ± 0.007 |
Uterus | 0.008 ± 0.002 | 0.055 ± 0.01 | 0.009 ± 0.003 |
Total body | 0.004 ± 0.001 | 0.004 ± 0.001 | 0.004 ± 0.001 |
Effective dose equivalent (mSv/MBq) | 0.017 ± 0.002 | 0.020 ± 0.012 | 0.019 ± 0.005 |
Effective dose (mSv/MBq) | 0.011 ± 0.001 | 0.012 ± 0.006 | 0.012 ± 0.003 |
Significant (P < 0.05) difference with absorbed dose after the injection of 1,000 μg 99mTc-(HE)3-G3.
LLI = lower large intestine; ULI = upper large intestine.